Wang YQ - Search Results

1

Vimentin and post-translational modifications in cell motility during cancer - a review.

Shi AM, Tao ZQ, Li R, Wang YQ, Wang X, Zhao J. Shi AM, et al. Among authors: wang x, wang yq. Eur Rev Med Pharmacol Sci. 2016 Jul;20(12):2603-6. Eur Rev Med Pharmacol Sci. 2016. PMID: 27383311 Free article. Review.

2

Cancer stem cells targeting agents--a review.

Shi AM, Tao ZQ, Li H, Wang YQ, Zhao J. Shi AM, et al. Among authors: wang yq. Eur Rev Med Pharmacol Sci. 2015 Nov;19(21):4064-7. Eur Rev Med Pharmacol Sci. 2015. PMID: 26592827 Free article. Review.

3

Intermediate filament Nestin and the cell motility in cancer - a review. Retracted.

Shi AM, Tao ZQ, Wang X, Wang YQ. Shi AM, et al. Among authors: wang x, wang yq. Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2598-602. Eur Rev Med Pharmacol Sci. 2016. Retraction in: Eur Rev Med Pharmacol Sci. 2016 Sep;20(17):3514. PMID: 27383310 Free article. Retracted. Review.

4

Role of microRNA in prostate cancer stem/progenitor cells regulation.

Tao ZQ, Shi AM, Li R, Wang YQ, Wang X, Zhao J. Tao ZQ, et al. Among authors: wang x, wang yq. Eur Rev Med Pharmacol Sci. 2016 Jul;20(14):3040-4. Eur Rev Med Pharmacol Sci. 2016. PMID: 27460733 Free article. Review.

5

Intermediate filament Nestin and the cell motility in cancer - a review.

Shi AM, Tao ZQ, Wang X, Wang YQ. Shi AM, et al. Among authors: wang x, wang yq. Eur Rev Med Pharmacol Sci. 2016 Sep;20(17):3514. Eur Rev Med Pharmacol Sci. 2016. PMID: 27649646 Free article. Review.

6

LncRNA FOXC2-AS1 regulated proliferation and apoptosis of vascular smooth muscle cell through targeting miR-1253/FOXF1 axis in atherosclerosis.

Wang YQ, Xu ZM, Wang XL, Zheng JK, Du Q, Yang JX, Zhang HC. Wang YQ, et al. Among authors: wang xl. Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3302-3314. doi: 10.26355/eurrev_202003_20698. Eur Rev Med Pharmacol Sci. 2020. PMID: 32271448 Free article.

7

Knockdown of CD24 inhibits proliferation, invasion and sensitizes breast cancer MCF-7 cells to tamoxifen in vitro.

Ma ZL, Chen YP, Song JL, Wang YQ. Ma ZL, et al. Among authors: wang yq. Eur Rev Med Pharmacol Sci. 2015 Jul;19(13):2394-9. Eur Rev Med Pharmacol Sci. 2015. PMID: 26214774 Free article.

8

Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein.

Wang YQ, Qu DH, Wang K. Wang YQ, et al. Among authors: wang k. Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2389-403. Eur Rev Med Pharmacol Sci. 2016. PMID: 27338066 Free article. Review.

9

MiR-222 promotes proliferation, migration and invasion of lung adenocarcinoma cells by targeting ETS1.

Sun Q, Jiang CW, Tan ZH, Hou LY, Dong H, Liu K, Sun G, Liu YJ, Wang YQ, Lu XC, Liu H. Sun Q, et al. Among authors: wang yq. Eur Rev Med Pharmacol Sci. 2017 May;21(10):2385-2391. Eur Rev Med Pharmacol Sci. 2017. PMID: 28617551 Free article.

10

Expressions and effects of G250, Bax and Bcl-2 in rats with renal clear cell carcinoma.

Wang YQ, Liu C, Shan ZF, Liu QZ, Cui YS, Yang LQ. Wang YQ, et al. Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4488-4492. doi: 10.26355/eurrev_201807_15502. Eur Rev Med Pharmacol Sci. 2018. PMID: 30058688 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,585 results

Search Page

Filters